Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever In other news, Director Ronald E. Blaylock purchased 19,457 shares of the ...

In related news, Director Ronald E. Blaylock acquired 19,457 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was bought at an average cost of $25.65 per share ...

Rep. Gilbert Ray Cisneros, Jr. recently sold Pfizer shares worth up to $50,000, marking another shake-up in his financial ...

StoneX Group clearly didn’t skip leg day—it just bulked up its Pfizer holdings by a massive 43.5% in Q4, scooping up over ...

Representative Rob Bresnahan, Jr. of Pennsylvania recently made headlines—not for legislation, but for investing between ...